HOUSTON and SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a...
false 0001595893 0001595893 2022-06-16 2022-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 Solicitation/Recommendation Statement...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE TOTENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)OF...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CTI BioPharma (CTIC – Research Report) and...
Bristol-Myers Squibb Company (NYSE: BMY) is all set to merge Turning Point Therapeutics, Inc. (NASDAQ: TPTX), an oncology company, into its...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bicycle Therapeutics (BCYC – Research Report...
false 0001595893 0001595893 2022-06-02 2022-06-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO TENDER...
By Colin Kellaher Shares of Turning Point Therapeutics Inc. took flight on Friday after the clinical-stage precision-oncology company agreed to be...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9...
false 0001595893 0001595893 2022-06-02 2022-06-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
By Colin Kellaher Bristol Myers Squibb Co. on Friday said it agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics...
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage...
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.